33 related articles for article (PubMed ID: 2593045)
1. A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer.
Zheng M; Wang Z; Li M; Yang N; Lu H; Zhang Z; Dong Y; Chen Y; Zhu Z; Tong A; Yang H
Transl Oncol; 2024 Jul; 45():101981. PubMed ID: 38703658
[TBL] [Abstract][Full Text] [Related]
2. Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice.
Deuschle FC; Schiefner A; Brandt C; Skerra A
Protein Sci; 2020 Aug; 29(8):1774-1783. PubMed ID: 32463547
[TBL] [Abstract][Full Text] [Related]
3. Development of a high affinity Anticalin
Deuschle FC; Morath V; Schiefner A; Brandt C; Ballke S; Reder S; Steiger K; Schwaiger M; Weber W; Skerra A
Theranostics; 2020; 10(5):2172-2187. PubMed ID: 32089738
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitylation of CD98 limits cell proliferation and clonal expansion.
Ablack JN; Metz PJ; Chang JT; Cantor JM; Ginsberg MH
J Cell Sci; 2015 Dec; 128(23):4273-8. PubMed ID: 26493331
[TBL] [Abstract][Full Text] [Related]
5. CD98 at the crossroads of adaptive immunity and cancer.
Cantor JM; Ginsberg MH
J Cell Sci; 2012 Mar; 125(Pt 6):1373-82. PubMed ID: 22499670
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.
Baird S
Crit Rev Clin Lab Sci; 1993; 30(1):1-28. PubMed ID: 8489735
[TBL] [Abstract][Full Text] [Related]
7. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Cunningham S
J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.
Schuurman HJ; Huppes W; Verdonck LF; Van Baarlen J; Van Unnik JA
Am J Pathol; 1988 Apr; 131(1):102-11. PubMed ID: 3258475
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
[TBL] [Abstract][Full Text] [Related]
10. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
